Autonomy Corporation Announcements

Spanish Healthcare Contract Win

06 November 2008 09:00:02



RNS Number : 5450H Autonomy Corporation PLC 06 November 2008  
?

Autonomy Editorial Contacts:
Assia Svinarova
Autonomy (UK)
+44 1223 448000
assias@autonomy.com

Laura Schaffer
Cohn & Wolfe (US) 
Laura.schaffer@cohnwolfe.com
+ 415-365-8557

Edward Bridges
Financial Dynamics (UK)
+44 207 831 3113
edward.bridges@fd.com
David Vindel
The Red Consultancy
+ 44 207 025 6529
david.vindel@redconsultancy.com

LEADING SPANISH HEALTH SERVICE PROVIDER SELECTS AUTONOMY FOR INNOVATION IN HEALTHCARE

Servicio Navarro de Salud to Use Pan-Enterprise Search Platform to Identify and Analyze Medical Trends

Cambridge, UK and San Francisco, Calif. - November 6, 2008 - Autonomy Corporation plc (LSE: AU. or AU.L), a global leader in infrastructure software for the enterprise today announced that Servicio Navarro de Salud (Osasunbidea), Spain's most innovative health service provider, has selected Autonomy's Intelligent Data Operating Layer (IDOL) to process, locate and identify trends within millions of medical records from hospitals and patients throughout the Navarra region. In a project pioneered by Autonomy and long-standing Autonomy partner Biko, IDOL will enable Osasunbidea to improve its healthcare services through a better understanding of patients' illnesses, the impact of local conditions, and the latest developments in treatment practices and clinical trials.

In the first stage of the deployment, Autonomy's award-winning Pan-Enterprise Search platform will help Osasunbidea to quickly and accurately manage and access millions of stored medical records, improving the health service provider's efficiency whilst allowing medical professionals to research, investigate and analyse medical histories and trends. Through IDOL functionality such as Conceptual Search, Entity Extraction and Hyperlinking, information and its related data will be found more easily, whilst IDOL's advanced security features will ensure patient privacy is respected. 

With Autonomy's Eduction functionality, Osasunbidea will ensure that it complies with Spain's Personal Data Protection policies. References to sensitive information, such as patients' personal details, can be automatically detected and removed. New versions are then generated, hyperlinked to other records and safely shared among the medical professionals. 

The second stage of the deployment will employ Autonomy's advanced functionality, such as Clustering technology, to analyse and visualize medical research results. Osasunbidea will cluster its research reports and findings for comparison and contrast over time. This will allow Osasunbidea to visualize, monitor and alert on unpredictable medical occurrences such as heat weaves or epidemics, as well as on standard information such as births and regular illnesses. Osasunbidea can also compare these trends year-over-year to spot tendencies and analyse patterns. Additionally, as part of this ground-breaking project, Osasunbidea will cluster emergency reports to analyse and compare yearly heat wave impacts and recurrent viruses on the Navarra population. 

"While currently most investigative questions are resolved by examining what has happened, we will be using Autonomy to know what is happening or predict what might happen in the future," commented Luis Larraya Galarza, Director del Complejo Médico Tecnológico de Navarra at Osasunbidea. "This means that we will have the latest medical information readily available. Autonomy IDOL will help us deliver the best medical service to our patients." 

"It is always great to see Autonomy's technology used in new, pioneering ways," said Mike Lynch, CEO of Autonomy. "This is a very exciting project which demonstrates Navarra's reputation within Spain for innovation and is at the forefront of medical research."
About Servicio Navarro de Salud (Osasunbidea)
Servicio Navarro de Salud, created by Leasehold Law 10/1990, on the 23rd November, is an autonomous organization, equipped with its own legal personnel and total legal capacity for the fulfillment of its aims. The aforementioned Law constitutes the legal guidelines for activities within healthcare, hygiene and medical assistance, for the Public Administrations of Navarra.

Servicio Navarro de Salud rests on a principle of improving medical assistance within two key areas: territorial, covering three key areas: Pamplona, Estella and Tudela, and functional, differentiating between Primary Attention and Specialized Attendance. 

The principle objectives of Servicio Navarro de Salud are oriented to the satisfaction of the legal requirements of healthcare whilst promoting health services, the prevention of disease and sanitary care.

About Biko
Biko is a leading technology consultancy focused on the public, media, financial and health sectors. Over the past years, Biko has accomplished important projects related to online marketing, Intranets and corporate portals, as well as management systems for organizations including Thomson, Reuters, Diario de Navarra, Grupo Eroski, Junta de Castilla y León, Caja Navarra, Agencia Efe, Servicio Navarro de Salud, Planeta Medios Interactivos, Gobierno de Navarra, Amma and Gobierno Vasco.

Biko's methodology incorporates important skills in developing user interfaces and efficient software integrations in order to solve the hardest business challenges for its clients in the Web 2.0 Economy. 

About Autonomy
Autonomy Corporation plc (LSE: AU. or AU.L), a global leader in infrastructure software for the enterprise, is spearheading the meaning-based computing movement and was recently ranked by IDC as the clear market share leader in enterprise search with market share nearly double that of its nearest competitor. Autonomy's technology allows computers to harness the full richness of human information, forming a conceptual and contextual understanding of any piece of electronic data including unstructured information, be it text, email, voice or video. Autonomy's software powers the full spectrum of mission-critical enterprise applications including information access technology, pan-enterprise search, information governance, end-to-end eDiscovery and archiving, records management, business process management, customer interaction solutions, and video and audio analysis, and is recognized by industry analysts as the clear leader in enterprise search.

Autonomy's customer base comprises of more than 17,000 global companies and organizations including: 3, ABN AMRO, AOL, BAE Systems, BBC, Bloomberg, Boeing, Citigroup, Coca Cola, Daimler Chrysler, Deutsche Bank, Ericsson, Ford, GlaxoSmithKline, Lloyd TSB, NASA, Nestle, the New York Stock Exchange, Reuters, Shell, T-Mobile, the U.S. Department of Energy, the U.S. Department of Homeland Security and the U.S. Securities and Exchange Commission. More than 350 companies OEM Autonomy technology, including BEA, Citrix, EDS, H-P, Novell, Oracle, Sybase and TIBCO, and the company has over 400 VARs and Systems Integrators. The company has offices worldwide. For more information on Autonomy, please visit www.autonomy.com.

Autonomy and the Autonomy logo are registered trademarks or trademarks of Autonomy Corporation plc. All other trademarks are the property of their respective owners.

This information is provided by RNSThe company news service from the London Stock Exchange  END  NRAUUGBPGUPRGQA

All data suppied by Digital Look (15 minute delay)




Risk Warning

There is an extra risk of losing money when shares are bought in some smaller companies including 'Penny Shares'. There is a big difference between the buying price and the selling price of these shares. If they have to be sold immediately, you may get back much less than you paid for them or you may have difficulty in selling them. Past performance is not a reliable indicator of future results. The price may change quickly and it may go down as well as up. You could lose every penny put into a particular share.

The information contained above has been compiled from documented sources which are believed to be reliable but, due to their very nature, are subject to a degree of historical inaccuracy and have not been independently verified and cannot be guaranteed. The pages on this website are provided for information only. City Equities Limited will not accept responsibility for loss incurred by any person or body acting, or refraining from acting, as a result of information and/or opinions given anywhere on this website. Issued by City Equities Limited, Aldermary House, 10-15 Queen Street, London, EC4N 1TY. Registered in England. Registered No. 2742847. Registered Address: Amwell House, 19 Amwell Street, Hoddeson, Herts. EN11 8TS. City Equities Limited is Authorised and regulated by the Financial Services Authority. Registration No. 155051.